Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-05-17 Purchase(A) |
2023-05-19 9:12 pm |
Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner |
96,000 | $13.22 | $1,269,375 | 7,000,000 (Indirect) |
View |
2023-05-17 Purchase |
2023-05-19 8:00 pm |
Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner |
60,000 | $13.07 | $784,228 | 6,964,000 (Indirect) |
View |
2023-05-11 Purchase |
2023-05-15 9:09 pm |
Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner |
290,000 | $12.34 | $3,577,411 | 6,904,000 (Indirect) |
View |
2023-03-10 Purchase |
2023-03-14 5:00 pm |
Innoviva Inc. | INVA | Raifeld Pavel Chief Executive Officer |
3,000 | $10.87 | $32,603 | 9,799 (Direct) |
View |
2022-07-08 Purchase |
2022-07-13 9:27 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
19,270,476 | $2.2 | $42,395,047 | 76,616,270 (Indirect Direct) |
View |
2022-03-31 Purchase |
2022-04-01 4:52 pm |
Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner |
5,385,208 | $5 | $26,926,040 | 44,441,416 (Indirect Direct) |
View |
2022-02-09 Purchase |
2022-02-11 6:56 pm |
Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner |
3,614,792 | $5 | $18,073,960 | 36,363,604 (Indirect Direct) |
View |
2021-10-29 Purchase |
2021-11-01 2:20 pm |
Armata Pharmaceuticals Inc. | ARMP | Innoviva Inc. Innoviva Strategic Opportunities LLC Director 10% Owner |
1,212,122 | $3.3 | $4,000,003 | 16,076,769 (Indirect Direct) |
View |
2021-08-20 Sale(A) |
2021-08-24 11:50 am |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
1,129 | $15.89 | $17,940 | 35,364 (Direct) |
View |
2021-08-19 Sale |
2021-08-23 5:02 pm |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
3,931 | $15.98 | $62,828 | 34,604 (Direct) |
View |
2021-06-11 Purchase |
2021-06-11 5:39 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
6,268,975 | $2 | $12,537,950 | 57,345,794 (Indirect Direct) |
View |
2021-05-21 Purchase |
2021-05-25 6:44 pm |
Innoviva Inc. | INVA | Bickerstaff George Director |
20,000 | $13.21 | $264,289 | 124,560 (Direct) |
View |
2021-05-20 Sale |
2021-05-24 5:04 pm |
Innoviva Inc. | INVA | GLAXOSMITHKLINE PLC 10% Owner |
32,005,260 | $12.25 | $392,064,435 | 0 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-05-22 Option Award |
2023-05-24 5:50 pm |
2024-05-22 2033-05-21 |
Innoviva Inc. | INVA | DiPaolo Mark Director |
26,495 | $0 | 124,706 (Direct) |
View |
2023-05-22 Option Award |
2023-05-24 5:47 pm |
2024-05-22 2033-05-21 |
Innoviva Inc. | INVA | Odysseas Kostas D Director |
26,495 | $0 | 128,702 (Direct) |
View |
2023-05-15 Option Award |
2023-05-23 4:30 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
1,576 | $0 | 51,937 (Direct) |
View |
2023-05-19 Tax Withholding |
2023-05-23 4:30 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
784 | $13.47 | 51,937 (Direct) |
View |
Ownership |
2023-05-15 9:05 pm |
N/A N/A |
Innoviva Inc. | INVA | DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner |
0 | $0 | 6,614,000 (Indirect) |
View |
2023-04-13 Option Award |
2023-04-17 7:27 pm |
2024-02-20 2033-04-12 |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
34,344 | $0 | 91,145 (Direct) |
View |
2023-02-17 Tax Withholding |
2023-02-22 4:31 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
1,852 | $12.42 | 36,801 (Direct) |
View |
Ownership |
2023-01-06 5:05 pm |
N/A N/A |
Innoviva Inc. | INVA | Srivastava Sapna Director |
0 | $0 | 16,178 (Direct) |
View |
2022-11-15 Option Award |
2022-11-22 4:30 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
433 | $0 | 38,653 (Direct) |
View |
2022-11-18 Tax Withholding |
2022-11-22 4:30 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
828 | $13.55 | 38,653 (Direct) |
View |
2022-08-19 Tax Withholding |
2022-08-22 6:16 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
830 | $14.12 | 39,048 (Direct) |
View |
2022-05-13 Option Award |
2022-05-23 4:31 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
1,834 | $0 | 39,878 (Direct) |
View |
2022-05-20 Tax Withholding |
2022-05-23 4:31 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
828 | $16.29 | 39,878 (Direct) |
View |
2022-05-02 Option Award |
2022-05-04 3:43 pm |
2023-05-20 2032-05-01 |
Innoviva Inc. | INVA | Raifeld Pavel Chief Executive Officer |
150,000 | $0 | 504,533 (Direct) |
View |
2022-04-25 Option Award |
2022-04-27 6:53 pm |
2023-04-25 2032-04-24 |
Innoviva Inc. | INVA | Birx Deborah Director |
22,647 | $0 | 52,489 (Direct) |
View |
2022-04-25 Option Award |
2022-04-27 6:52 pm |
2023-04-25 2032-04-24 |
Innoviva Inc. | INVA | Bickerstaff George Director |
22,647 | $0 | 147,207 (Direct) |
View |
2022-04-25 Option Award |
2022-04-27 6:51 pm |
2023-04-25 2032-04-24 |
Innoviva Inc. | INVA | Haimovitz Jules Director |
22,647 | $0 | 110,411 (Direct) |
View |
2022-04-25 Option Award |
2022-04-27 6:49 pm |
2023-04-25 2032-04-24 |
Innoviva Inc. | INVA | DiPaolo Mark Director |
22,647 | $0 | 98,211 (Direct) |
View |
2022-04-25 Option Award |
2022-04-27 6:48 pm |
2023-04-25 2032-04-24 |
Innoviva Inc. | INVA | Schlesinger Sarah J. Director |
22,647 | $0 | 98,211 (Direct) |
View |
2022-04-25 Option Award |
2022-04-27 6:47 pm |
N/A N/A |
Innoviva Inc. | INVA | Odysseas Kostas D Director |
12,647 | $0 | 92,207 (Direct) |
View |
2022-04-25 Option Award |
2022-04-27 6:47 pm |
2023-04-25 2032-04-24 |
Innoviva Inc. | INVA | Odysseas Kostas D Director |
10,000 | $10,000 | 92,207 (Direct) |
View |
2022-03-01 Option Award |
2022-03-02 8:40 pm |
2023-02-20 2032-02-28 |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
21,691 | $0 | 58,872 (Direct) |
View |
2022-02-18 Other |
2022-02-23 1:05 pm |
N/A 2022-08-18 |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
0 | $0 | 57,345,794 (Indirect) |
View |
2022-02-18 Tax Withholding |
2022-02-22 5:06 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
2,277 | $19.99 | 32,181 (Direct) |
View |
2021-11-19 Tax Withholding |
2021-11-22 5:01 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
758 | $17.05 | 34,458 (Direct) |
View |
2021-08-20 Tax Withholding |
2021-08-23 5:02 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
760 | $15.94 | 34,604 (Direct) |
View |
2021-05-21 Option Award |
2021-05-25 6:43 pm |
2022-05-20 2031-05-21 |
Innoviva Inc. | INVA | Raifeld Pavel Chief Executive Officer |
100,000 | $0 | 352,500 (Direct) |
View |
2021-05-20 Tax Withholding |
2021-05-24 5:19 pm |
N/A N/A |
Innoviva Inc. | INVA | Zhen Marianne Chief Accounting Officer |
759 | $13.32 | 39,295 (Direct) |
View |
2021-05-14 Option Award |
2021-05-20 8:17 pm |
N/A N/A |
Innoviva Inc. | INVA | Haimovitz Jules Director |
17,482 | $0 | 87,764 (Direct) |
View |
2021-05-14 Option Award |
2021-05-20 8:16 pm |
N/A N/A |
Innoviva Inc. | INVA | Bickerstaff George Director |
17,482 | $0 | 104,560 (Direct) |
View |